This Is MS Multiple Sclerosis Knowledge & Support Community

The Tisch MS Research Center of New York announced today that it has received Investigational New Drug (IND) approval from the Food and Drug Administration (FDA) to commence a Phase 1 trial using autologous neural stem cells in the treatment of multiple sclerosis (MS). MS is a chronic human autoimmune disease of the central nervous system that leads to myelin damage and neurodegeneration and affects approximately 2.1 million people worldwide....... Read More - http://www.ms-uk.org/index.cfm/stemcells

nataliasmith wrote:I realize there are many people with MS who are suffering and for whom today’s conventional medicine has too little to offer, but at least for now I believe that stem cells are not the answer. The risks from stem cell interventions for MS today such as infection, cancer, pulmonary embolism, and worsening of immune symptoms

How did you come to this conclusion? Because as far as I know there is not a single death from HSCT, something that cannot be said for any other treatment.